Fact checked by Jennifer Klump Key Takeaways The American Cancer Society now recommends stool-based tests and a blood test as ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. And while colonoscopy remains the gold standard for ...

Colorectal Cancer Awareness Month is observed every year during March and aims to promote screening and early detection, raise awareness, and offer support to those battling the disease. Since March ...

The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Building ...

The Food and Drug Administration (FDA) has approved the Cologuard Plus™ test for colorectal cancer screening in adults aged 45 years and older who are at average risk for colorectal cancer. According ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

An ongoing theme among medical marketing is the increasingly common embrace of Spanish-language marketing by health brands. Considering there are more than 41 million Spanish speakers in the U.S., ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Exact Sciences won Food and Drug Administration ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A blood test that accurately detects colon cancer in middle-aged and ...

Chicago-based Blue Cross Blue Shield Association contracted with Exact Sciences Corp. in Madison, Wis., to cover Cologuard — a cancer screening — as an in-network service for its policyholders. About ...

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults aged 45 years at average risk for colorectal cancer. The Food and Drug Administration (FDA) has approved the ...